Northway Biotech
24.5.2023 18:24:40 CEST | ACCESS Newswire | Press release
WALTHAM, MA / ACCESSWIRE / May 24, 2023 / Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art cGMP manufacturing site in Vilnius, Lithuania, announced the completion of its expansion project for cGMP manufacturing facilities in Waltham, Massachusetts. This significant accomplishment further solidifies Northway Biotech's standing as an influential player in the global biopharmaceutical landscape.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.This recent growth is an extension of the successful launch of Northway Biotech's process and analytical development laboratories in Waltham (Greater Boston area) in 2020. The expanded facility now includes state-of-the-art cGMP suites, marking a significant milestone in the company's journey. The newly established cutting-edge biomanufacturing suites host a microbial fermentation train with up to 450 liters of volume capacity, and a mammalian production train with the ability to handle volumes of up to 2,000 liters. Northway Biotech has further established a specialized, fully automated fill and finish line to accommodate its clients' varied needs, supporting high-throughput filling into vials, syringes, and cartridges.
Prof. Vladas Algirdas Bumelis, CEO of Northway Biotech, shared his insights regarding this accomplishment, stating, "The addition of GMP suites in our US site represents a transformative step for our organization, enabling us to provide comprehensive end-to-end solutions from our second site now. We are poised to transition current process development projects into the cGMP manufacturing phase in a timely manner, in line with our clients' committed schedules. Additionally, our longstanding US partners who have engaged with our Lithuanian site can now also take advantage of the geographical convenience of our modern facilities located in the Greater Boston Area. With our fully functional and technologically advanced manufacturing site at our disposal, Northway Biotech is perfectly positioned to take on manufacturing projects aimed at both clinical and commercial supply."
To commemorate this significant expansion and express gratitude to its valued partners and industry leaders, Northway Biotech will be hosting a grand opening event for its cGMP suites on June 8. This event promises to be an occasion of celebration and networking, providing an opportunity for attendees to witness firsthand the state-of-the-art facilities and engage in meaningful discussions within the biotech community.
About Northway Biotech - https://www.northwaybiotech.com
Northway Biotech is a leading contract development and manufacturing organization (CDMO) supporting customers worldwide. Its highly experienced, professional team executes projects at any stage, from cell line construction and process development to cGMP manufacturing of biopharmaceutical products. The company's wide-ranging expertise and vertically integrated service offering translate to the ability to rapidly execute multiple projects from its state-of-the-art GMP facilities while ensuring full process and product compliance at all stages of research, development and commercial manufacturing. Northway Biotech is a privately-owned company founded in 2004 and located in Vilnius, Lithuania; London, United Kingdom; and Waltham, Massachusetts, United States.
For Further Information, Contact:
Prof. Vladas Algirdas Bumelis
CEO and Chairman of the Board
Northway Biotech
vladas.bumelis@northwaybiotech.com
Contact Information
Vladas Bumelis
CEO and Chairman of the Board
vladas.bumelis@northwaybiotech.com
SOURCE: Northway Biotech
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/757061/Northway-Biotech-Set-to-Launch-Advanced-Microbial-and-Mammalian-GMP-Facilities-in-Massachusetts
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
ComplianceQuest and Zolon PCS Selected to Modernize U.S. Food and Drug Administration (FDA) Enterprise Quality Management System6.10.2026 18:00:00 CEST | Press release
TAMPA, FL / ACCESS Newswire / October 6, 2026 / ComplianceQuest, a leading provider of AI-powered connected Quality, Risk and Compliance (QRC) systems, and Zolon PCS, a provider of secure, mission-focused IT services to federal agencies, today announced that the U.S. Food and Drug Administration (FDA) will modernize its enterprise quality management operations on the ComplianceQuest platform. The initiative will be delivered under the FDA Cloud Quality Management System Blanket Purchase Agreement (BPA), a five-year agreement awarded to Zolon PCS as prime contractor, with ComplianceQuest as its platform partner. Together, ComplianceQuest and Zolon PCS will help FDA implement a modern, secure, AI-enabled quality management solution built on the Salesforce FedRAMP Government Cloud platform. The solution is designed to strengthen compliance, improve consistency, streamline quality processes, and deliver greater insight across FDA's centers and offices. The initiative will focus on four pri
Stagwell Launches New Global Media Agency, Stagwell Media6.10.2026 15:45:00 CEST | Press release
NEW YORK CITY, NY / ACCESS Newswire / October 6, 2026 / Stagwell (NASDAQ:STGW), the global challenger network transforming marketing through AI, today announced the launch of Stagwell Media, its global media agency that delivers performance built to unlock ambition. The name Stagwell Media marks a new approach to media building on the Assembly agency, bringing together its performance heritage and ecosystem expertise while debuting a new agile, integrated model powered by next generation agentic technology, Stagwell's Machine OS. Designed for the rapidly changing media landscape, Stagwell Media delivers performance with the speed, flexibility and intelligence required to succeed in a world where brands must engage priority audiences while influencing the agentic systems that shape discovery, recommendation and activation.By transforming media into a more connected and adaptive growth engine, the agency empowers brands to unlock greater ambition and drive stronger business results. "The
Valsoft Corporation Announces Acquisition of the Firebrand Group Collection of Companies6.10.2026 14:50:00 CEST | Press release
MONTRÉAL, QC / ACCESS Newswire / October 6, 2026 / Valsoft Corporation Inc. ("Valsoft"), a Montreal-based company specializing in the acquisition and development of vertical market software businesses, today announced the acquisition of Firebrand Technologies ("Firebrand"), NetGalley LLC ("NetGalley"), and Supadu Ltd ("Supadu"), together known as the Firebrand Group, a global collection of companies providing leading software and services that help publishers succeed. Valsoft acquired the Firebrand Group from Media Do International, the US-based subsidiary of MEDIA DO Ltd., in Japan. Founded in 1987 and headquartered in Newburyport, Massachusetts, Firebrand Technologies provides title management and metadata software publishers use to plan, manage, and distribute book data to retailers and trading partners around the world. Its flagship platform, Title Management Enterprise, runs the publishing workflow from acquisition through publication, keeping schedules, rights, costs,
U.S. Polo Assn. Celebrates an Outstanding 2026 European Polo Season6.10.2026 13:00:00 CEST | Press release
WEST PALM BEACH, FL / ACCESS Newswire / October 6, 2026 / U.S. Polo Assn.®, the official sports brand of the United States Polo Association (USPA), supported several major sports events across Europe during the 2026 summer season, reinforcing the brand's authentic connection to the sport across the continent. U.S. Polo Assn. served as the Official Apparel and Jersey Sponsor for multiple events, including:55th Sotogrande International Polo Tournament at Ayala Polo Club in Sotogrande, Spain;Barnes French Open at Polo Club de Chantilly in France;Engel & Völkers Berlin Maifeld Polo Cup in Germany;Museumplein Polo Amsterdam in the Netherlands; Barnes French Open Winners, Kazak, on stage with trophy at Polo Club de Chantilly in France Across these partnerships, U.S. Polo Assn. outfitted players, umpires, and event staff while supporting competition ranging from historic high-goal championships in iconic venues throughout the region. "U.S. Polo Assn.'s presence across Europe reflects both the
Synexis and Customate Collaborate to Advance Continuous Indoor Pathogen Control for the U.K. Poultry Industry5.10.2026 22:10:00 CEST | Press release
OVERLAND PARK, KS AND YORKSHIRE, ENGLAND / ACCESS Newswire / October 5, 2026 / Synexis®, LLC, the leader in touchless, continuous pathogen control technology, has announced a strategic collaboration with Customate Solutions, a family-owned engineering company and trusted provider of innovative manufacturing solutions with deep expertise across the poultry industry. The collaboration will bring Synexis patented DHP® technology to poultry producers throughout the United Kingdom and Ireland, helping hatcheries, poultry farms, processing facilities, and related operations strengthen indoor pathogen control while supporting modern biosecurity strategies. Poultry producers today face increasing pressure to maximize healthy hatch rates, improve chick quality, and strengthen biosecurity while reducing operational risk. Bacterial contamination on hatching eggs and throughout hatchery environments can directly impact hatchability, flock health, and production performance, making effective pathog
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom